Incidence of Nonvertebral Fractures in Relation to Time on Treatment and Bone Density in Glucocorticoid-Treated Patients: A Retrospective Approach

Journal of Clinical Rheumatology

Volumn 9, Issue 3, 2003, Pages 170-175

  Goemaere, Stefan ^a   Liberman, U A ^b   Adachi, J D ^c   Hawkins, F ^d   Lane, N ^e   Saag, K G ^f   Schnitzer, T ^a   Kaufman, J M ^a   Malice, M P ^b   Carofano, W ^b   Daifotis, A ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b RABIN MEDICAL CENTER   (Israel)

^c ST JOSEPH S HOSPITAL   (Canada)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bone mineral density; Fracture; Glucocorticoids

Indexed keywords

ALENDRONIC ACID; GLUCOCORTICOID; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; FRACTURE; HIP; HUMAN; INCIDENCE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NONVERTEBRAL FRACTURE; OSTEOLYSIS; PATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPINE; TIME; VERTEBRA;

EID: 0344823890     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RHU.0000073586.28977.31     Document Type: Article

References (14)

1. Curtiss PH, Clark WS, Herndon CH. Vertebral fractures resulting from prolonged cortisone and corticotrophin therapy. JAMA. 1954;156:467-469.
2. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990;112:352-364.
3. Hahn TJ, Halstead LR, Baran DR. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab. 1981;52:111.
4. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis. 1986;45:852-857.
5. Van Staa TP, Leufkens HGM, Abenhaim L, et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15:933-1000.
6. Gennari C, Civitelli R. Glucocorticoid-induced osteoporosis. Clin Rheumatol. 1986;12:637-654.
7. Sambrook P, Birmingham J, Kempler S, et al. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res. 1990;5:1221-1225.
8. World Health Organisation. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis: Technical Report Series No. 843. Geneva: WHO; 1984.
9. De Laet C, van Hout BA, Burger H, et al. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res. 1998;13:1587-1593.
10. Saag KG, Emkey R, Schnitzer TJ, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med. 1998;339:292-299.
11. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
12. Luengo M, Picado C, Rio LD, et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax. 1991;46:803-806.
13. Peel NFA, Moore DJ, Barrington NA, et al. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis. 1995;54:801-806.
14. Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med. 1990;150:2545-2548.